Grantham, Mayo, Van Otterloo & Co (GMO)’s XPEL XPEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5M Buy
232,313
+34,438
+17% +$1.57M 0.03% 242
2026
Q1
$8.76M Buy
197,875
+2,277
+1% +$109K 0.02% 254
2025
Q4
$9.76M Sell
195,598
-135,238
-41% -$5.65M 0.03% 238
2025
Q3
$10.9M Buy
330,836
+3,089
+0.9% +$110K 0.03% 231
2025
Q2
$11.8M Buy
327,747
+16,008
+5% +$528K 0.04% 218
2025
Q1
$9.16M Buy
311,739
+69,155
+29% +$2.59M 0.03% 251
2024
Q4
$9.69M Buy
242,584
+11,463
+5% +$489K 0.03% 257
2024
Q3
$10M Buy
231,121
+23,771
+11% +$959K 0.03% 272
2024
Q2
$7.37M Buy
207,350
+35,075
+20% +$1.51M 0.02% 290
2024
Q1
$9.31M Buy
172,275
+116,185
+207% +$6.09M 0.03% 264
2023
Q4
$3.02M Buy
56,090
+15,083
+37% +$810K 0.01% 328
2023
Q3
$3.16M Buy
+41,007
New +$3.3M 0.01% 358

Other funds holding XPEL

Grantham, Mayo, Van Otterloo & Co (GMO)'s XPEL Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its XPEL (XPEL) stake by 17% in Q2 2026, buying an estimated $1.57M and bringing the position to 232,313 shares worth $11.5M. The position accounts for 0.03% of the portfolio, ranked #242.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in XPEL in Q3 2023 and has held it in 12 quarters since. The position peaked at $11.8M in Q2 2025. 210 funds tracked by Wall St. Rank hold XPEL as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 232,313 shares of XPEL worth $11.5M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 34,438 XPEL shares in Q2 2026, an estimated $1.57M.
  • XPEL made up 0.03% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #242 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in XPEL in Q3 2023 and has held it in 12 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s XPEL position peaked at $11.8M in Q2 2025.
  • 210 funds tracked by Wall St. Rank held XPEL as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.